Display options
Share it on

Case Rep Med. 2010;2010:534027. doi: 10.1155/2010/534027. Epub 2010 Mar 11.

A false case of clozapine-resistant schizophrenia.

Case reports in medicine

J P Maia-de-Oliveira, J P Pinto, V Alexandre, J P Machado-de-Sousa, S L Morais, C Chaves, A C Sakamoto, A W Zuardi, J A S Crippa, J E Hallak

Affiliations

  1. Department of Neuroscience and Behavioral Sciences, Ribeirao Preto Medical School, University of São Paulo (USP), Hospital das Clinicas, TerceiroAndar, AvenidaBandeirantes Campus Universitario, 3900, Ribeirao Preto, SP 14049-900, Brazil.

PMID: 20300582 PMCID: PMC2837900 DOI: 10.1155/2010/534027

Abstract

One of the subjects that most concerns physicians is treatment-resistance. About 30%-60% of schizophrenia patients do not respond adequately to antipsychotic treatment and are known as refractory schizophrenia patients. Clozapine has been the drug of choice in such cases. However, approximately 30% of them do not respond to clozapine either. Here, we describe a patient with an initial diagnosis of refractory schizophrenia who had a history of dramatic aggressiveness. However, in this case, "refractoriness" was a wrong diagnosis. A case of psychosis secondary to epilepsy had been treated as schizophrenia for almost 20 years. Reports like this one are important because they remind us of how a thorough investigation can lead to the correct diagnosis and improve the patient's prognosis.

References

  1. Epilepsia. 2002 Dec;43(12):1574-82 - PubMed
  2. Neurology. 1999;53(5 Suppl 2):S33-8 - PubMed
  3. Lancet. 2009 Jan 3;373(9657):31-41 - PubMed
  4. Epilepsia. 2001 Nov;42(11):1468-71 - PubMed
  5. Braz J Psychiatry. 2007 Sep;29(3):228-32 - PubMed

Publication Types